These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21448434)

  • 1. Redox regulation of insulin degradation by insulin-degrading enzyme.
    Cordes CM; Bennett RG; Siford GL; Hamel FG
    PLoS One; 2011 Mar; 6(3):e18138. PubMed ID: 21448434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation.
    Cordes CM; Bennett RG; Siford GL; Hamel FG
    Biochem Pharmacol; 2009 Mar; 77(6):1064-73. PubMed ID: 19154729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin acts intracellularly on proteasomes through insulin-degrading enzyme.
    Duckworth WC; Bennett RG; Hamel FG
    Biochem Biophys Res Commun; 1998 Mar; 244(2):390-4. PubMed ID: 9514933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of amylin by insulin-degrading enzyme.
    Bennett RG; Duckworth WC; Hamel FG
    J Biol Chem; 2000 Nov; 275(47):36621-5. PubMed ID: 10973971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin inhibition of the proteasome is dependent on degradation of insulin by insulin-degrading enzyme.
    Bennett RG; Fawcett J; Kruer MC; Duckworth WC; Hamel FG
    J Endocrinol; 2003 Jun; 177(3):399-405. PubMed ID: 12773120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the insulin inhibition of the peptidolytic activities of the insulin-degrading enzyme-proteasome complex.
    Bennett RG; Hamel FG; Duckworth WC
    Diabetes; 1997 Feb; 46(2):197-203. PubMed ID: 9000694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease intervention.
    Zhao L; Teter B; Morihara T; Lim GP; Ambegaokar SS; Ubeda OJ; Frautschy SA; Cole GM
    J Neurosci; 2004 Dec; 24(49):11120-6. PubMed ID: 15590928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
    Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S
    Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme.
    Kurochkin IV; Goto S
    FEBS Lett; 1994 May; 345(1):33-7. PubMed ID: 8194595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Insulin-Degrading Enzyme to Treat Type 2 Diabetes Mellitus.
    Tang WJ
    Trends Endocrinol Metab; 2016 Jan; 27(1):24-34. PubMed ID: 26651592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains.
    Pérez A; Morelli L; Cresto JC; Castaño EM
    Neurochem Res; 2000 Feb; 25(2):247-55. PubMed ID: 10786709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transepithelial transport of insulin: I. Insulin degradation by insulin-degrading enzyme in small intestinal epithelium.
    Bai JP; Chang LL
    Pharm Res; 1995 Aug; 12(8):1171-5. PubMed ID: 7494830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis for the recognition and cleavages of IGF-II, TGF-alpha, and amylin by human insulin-degrading enzyme.
    Guo Q; Manolopoulou M; Bian Y; Schilling AB; Tang WJ
    J Mol Biol; 2010 Jan; 395(2):430-43. PubMed ID: 19896952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation.
    Qiu WQ; Walsh DM; Ye Z; Vekrellis K; Zhang J; Podlisny MB; Rosner MR; Safavi A; Hersh LB; Selkoe DJ
    J Biol Chem; 1998 Dec; 273(49):32730-8. PubMed ID: 9830016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme.
    Vekrellis K; Ye Z; Qiu WQ; Walsh D; Hartley D; Chesneau V; Rosner MR; Selkoe DJ
    J Neurosci; 2000 Mar; 20(5):1657-65. PubMed ID: 10684867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis.
    Qiu WQ; Folstein MF
    Neurobiol Aging; 2006 Feb; 27(2):190-8. PubMed ID: 16399206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IDE Degrades Nociceptin/Orphanin FQ through an Insulin Regulated Mechanism.
    Zingale GA; Bellia F; Ahmed IMM; Mielczarek P; Silberring J; Grasso G
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31509943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular bases for the recognition of short peptide substrates and cysteine-directed modifications of human insulin-degrading enzyme.
    Malito E; Ralat LA; Manolopoulou M; Tsay JL; Wadlington NL; Tang WJ
    Biochemistry; 2008 Dec; 47(48):12822-34. PubMed ID: 18986166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme.
    McDermott JR; Gibson AM
    Neurochem Res; 1997 Jan; 22(1):49-56. PubMed ID: 9021762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme.
    Zhang Z; Liang WG; Bailey LJ; Tan YZ; Wei H; Wang A; Farcasanu M; Woods VA; McCord LA; Lee D; Shang W; Deprez-Poulain R; Deprez B; Liu DR; Koide A; Koide S; Kossiakoff AA; Li S; Carragher B; Potter CS; Tang WJ
    Elife; 2018 Mar; 7():. PubMed ID: 29596046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.